
His career has moved through the hidden machinery of modern medicine - supply nodes, manufacturing platforms and commercial partnerships. At ABL Ascend, Suman Subramanian is betting that the clearest route through complexity begins with making it simpler for customers.
He does not develop the drug or run the ads. He makes sure the thing gets made, on spec, on time, batch after batch - across a network of factories Takeda does not own.